Answers are grounded in this paper and cite their sources.
Insights reveal nanocarriers improve drug delivery in ocular therapeutics, highlighting pharmacotherapeutic challenges.
Ocular fungal infections pose particularly significant pharmacotherapeutic challenges due to the intricate anatomical and physiological features of the eye, which hinder the efficient delivery of therapeutic agents to targeted ocular areas.
No takes yet. Share an insight, caveat, or question.
Sil et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: